[
  {
    "title": "Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages - MarketBeat",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages - MarketBeat"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/"
      }
    ],
    "link": "https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/",
    "id": "CBMiV2h0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1teW9rLWNvbnNlbnN1cy1hbmFseXN0LXJhdGluZy0yMDIwLTEwL9IBW2h0dHBzOi8vd3d3Lm1hcmtldGJlYXQuY29tL2luc3RhbnQtYWxlcnRzL25hc2RhcS1teW9rLWNvbnNlbnN1cy1hbmFseXN0LXJhdGluZy0yMDIwLTEwL2FtcC8",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:37:34 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      37,
      34,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/\" target=\"_blank\">Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketbeat.com/instant-alerts/nasdaq-myok-consensus-analyst-rating-2020-10/\" target=\"_blank\">Myokardia Inc (NASDAQ:MYOK) Given Consensus Recommendation of \"Buy\" by Brokerages</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>"
    },
    "source": {
      "href": "https://www.marketbeat.com",
      "title": "MarketBeat"
    },
    "sub_articles": []
  },
  {
    "title": "Is Myokardia Inc (MYOK) The Right Choice in Biotechnology? - InvestorsObserver",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Is Myokardia Inc (MYOK) The Right Choice in Biotechnology? - InvestorsObserver"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.investorsobserver.com/news/stock-update/is-myokardia-inc-myok-the-right-choice-in-biotechnology"
      }
    ],
    "link": "https://www.investorsobserver.com/news/stock-update/is-myokardia-inc-myok-the-right-choice-in-biotechnology",
    "id": "CBMia2h0dHBzOi8vd3d3LmludmVzdG9yc29ic2VydmVyLmNvbS9uZXdzL3N0b2NrLXVwZGF0ZS9pcy1teW9rYXJkaWEtaW5jLW15b2stdGhlLXJpZ2h0LWNob2ljZS1pbi1iaW90ZWNobm9sb2d50gFvaHR0cHM6Ly93d3cuaW52ZXN0b3Jzb2JzZXJ2ZXIuY29tL25ld3Mvc3RvY2stdXBkYXRlL2FtcC9pcy1teW9rYXJkaWEtaW5jLW15b2stdGhlLXJpZ2h0LWNob2ljZS1pbi1iaW90ZWNobm9sb2d5",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:57:57 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      57,
      57,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.investorsobserver.com/news/stock-update/is-myokardia-inc-myok-the-right-choice-in-biotechnology\" target=\"_blank\">Is Myokardia Inc (MYOK) The Right Choice in Biotechnology?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">InvestorsObserver</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.investorsobserver.com/news/stock-update/is-myokardia-inc-myok-the-right-choice-in-biotechnology\" target=\"_blank\">Is Myokardia Inc (MYOK) The Right Choice in Biotechnology?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">InvestorsObserver</font>"
    },
    "source": {
      "href": "https://www.investorsobserver.com",
      "title": "InvestorsObserver"
    },
    "sub_articles": []
  },
  {
    "title": "W2O Works Media for MyoKardia - Mon., Oct. 5, 2020 - O'Dwyer's PR News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "W2O Works Media for MyoKardia - Mon., Oct. 5, 2020 - O'Dwyer's PR News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.odwyerpr.com/story/public/14977/2020-10-05/w2o-works-media-for-myokardia.html"
      }
    ],
    "link": "https://www.odwyerpr.com/story/public/14977/2020-10-05/w2o-works-media-for-myokardia.html",
    "id": "CBMiWWh0dHBzOi8vd3d3Lm9kd3llcnByLmNvbS9zdG9yeS9wdWJsaWMvMTQ5NzcvMjAyMC0xMC0wNS93Mm8td29ya3MtbWVkaWEtZm9yLW15b2thcmRpYS5odG1s0gEA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:04:18 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      4,
      18,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.odwyerpr.com/story/public/14977/2020-10-05/w2o-works-media-for-myokardia.html\" target=\"_blank\">W2O Works Media for MyoKardia - Mon., Oct. 5, 2020</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">O'Dwyer's PR News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.odwyerpr.com/story/public/14977/2020-10-05/w2o-works-media-for-myokardia.html\" target=\"_blank\">W2O Works Media for MyoKardia - Mon., Oct. 5, 2020</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">O'Dwyer's PR News</font>"
    },
    "source": {
      "href": "https://www.odwyerpr.com",
      "title": "O'Dwyer's PR News"
    },
    "sub_articles": []
  },
  {
    "title": "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of MyoKardia, Inc. to Bristol Myers Squibb - Yahoo Finance",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of MyoKardia, Inc. to Bristol Myers Squibb - Yahoo Finance"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-142000517.html"
      }
    ],
    "link": "https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-142000517.html",
    "id": "CBMiUmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zaGFyZWhvbGRlci1hbGVydC1sZXZpLWtvcnNpbnNreS1sbHAtMTQyMDAwNTE3Lmh0bWzSAVpodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9zaGFyZWhvbGRlci1hbGVydC1sZXZpLWtvcnNpbnNreS1sbHAtMTQyMDAwNTE3Lmh0bWw",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:20:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      20,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-142000517.html\" target=\"_blank\">SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of MyoKardia, Inc. to Bristol Myers Squibb</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-142000517.html\" target=\"_blank\">SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of MyoKardia, Inc. to Bristol Myers Squibb</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>"
    },
    "source": {
      "href": "https://finance.yahoo.com",
      "title": "Yahoo Finance"
    },
    "sub_articles": []
  },
  {
    "title": "Bristol Myers Squibb buys biopharma MyoKardia for $13B - UPI News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Bristol Myers Squibb buys biopharma MyoKardia for $13B - UPI News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.upi.com/Top_News/US/2020/10/05/Bristol-Myers-Squibb-buys-biopharma-MyoKardia-for-13B/2021601902635/"
      }
    ],
    "link": "https://www.upi.com/Top_News/US/2020/10/05/Bristol-Myers-Squibb-buys-biopharma-MyoKardia-for-13B/2021601902635/",
    "id": "CAIiELa6Dz57uX4h78HPEnr308gqGAgEKg8IACoHCAowyrnjAjC42xswyM2eBg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:43:16 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      43,
      16,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.upi.com/Top_News/US/2020/10/05/Bristol-Myers-Squibb-buys-biopharma-MyoKardia-for-13B/2021601902635/\" target=\"_blank\">Bristol Myers Squibb buys biopharma MyoKardia for $13B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">UPI News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.upi.com/Top_News/US/2020/10/05/Bristol-Myers-Squibb-buys-biopharma-MyoKardia-for-13B/2021601902635/\" target=\"_blank\">Bristol Myers Squibb buys biopharma MyoKardia for $13B</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">UPI News</font>"
    },
    "source": {
      "href": "https://www.upi.com",
      "title": "UPI News"
    },
    "sub_articles": []
  },
  {
    "title": "Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp? - PRNewswire",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp? - PRNewswire"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html"
      }
    ],
    "link": "https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html",
    "id": "CBMihwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3Nob3VsZC15b3UtaW52ZXN0LWluLXNxdWFyZS1teW9rYXJkaWEtZ2lsZWFkLXNjaWVuY2VzLWRvY3VzaWduLW9yLWNhcm5pdmFsLWNvcnAtMzAxMTQ1NzA1Lmh0bWzSAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:35:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      35,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html\" target=\"_blank\">Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PRNewswire</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.prnewswire.com/news-releases/should-you-invest-in-square-myokardia-gilead-sciences-docusign-or-carnival-corp-301145705.html\" target=\"_blank\">Should you invest in Square, Myokardia, Gilead Sciences, Docusign, or Carnival Corp?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PRNewswire</font>"
    },
    "source": {
      "href": "https://www.prnewswire.com",
      "title": "PRNewswire"
    },
    "sub_articles": []
  },
  {
    "title": "Wall Street claws back more of its losses on stimulus hopes - FOX5 Las Vegas",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Wall Street claws back more of its losses on stimulus hopes - FOX5 Las Vegas"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.fox5vegas.com/coronavirus/wall-street-claws-back-more-of-its-losses-on-stimulus-hopes/article_9ab7c2bc-ef8e-5558-a7f0-8176d3401e04.html"
      }
    ],
    "link": "https://www.fox5vegas.com/coronavirus/wall-street-claws-back-more-of-its-losses-on-stimulus-hopes/article_9ab7c2bc-ef8e-5558-a7f0-8176d3401e04.html",
    "id": "CBMikwFodHRwczovL3d3dy5mb3g1dmVnYXMuY29tL2Nvcm9uYXZpcnVzL3dhbGwtc3RyZWV0LWNsYXdzLWJhY2stbW9yZS1vZi1pdHMtbG9zc2VzLW9uLXN0aW11bHVzLWhvcGVzL2FydGljbGVfOWFiN2MyYmMtZWY4ZS01NTU4LWE3ZjAtODE3NmQzNDAxZTA0Lmh0bWzSAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:57:14 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      57,
      14,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.fox5vegas.com/coronavirus/wall-street-claws-back-more-of-its-losses-on-stimulus-hopes/article_9ab7c2bc-ef8e-5558-a7f0-8176d3401e04.html\" target=\"_blank\">Wall Street claws back more of its losses on stimulus hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FOX5 Las Vegas</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.fox5vegas.com/coronavirus/wall-street-claws-back-more-of-its-losses-on-stimulus-hopes/article_9ab7c2bc-ef8e-5558-a7f0-8176d3401e04.html\" target=\"_blank\">Wall Street claws back more of its losses on stimulus hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FOX5 Las Vegas</font>"
    },
    "source": {
      "href": "https://www.fox5vegas.com",
      "title": "FOX5 Las Vegas"
    },
    "sub_articles": []
  },
  {
    "title": "Harvard 'MacArthur genius' Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin - Endpoints News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Harvard 'MacArthur genius' Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin - Endpoints News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://endpts.com/harvard-macarthur-genius-kevin-eggan-steps-in-to-run-early-stage-research-at-rare-disease-specialist-biomarin/"
      }
    ],
    "link": "https://endpts.com/harvard-macarthur-genius-kevin-eggan-steps-in-to-run-early-stage-research-at-rare-disease-specialist-biomarin/",
    "id": "CBMigQFodHRwczovL2VuZHB0cy5jb20vaGFydmFyZC1tYWNhcnRodXItZ2VuaXVzLWtldmluLWVnZ2FuLXN0ZXBzLWluLXRvLXJ1bi1lYXJseS1zdGFnZS1yZXNlYXJjaC1hdC1yYXJlLWRpc2Vhc2Utc3BlY2lhbGlzdC1iaW9tYXJpbi_SAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:45:59 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      45,
      59,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://endpts.com/harvard-macarthur-genius-kevin-eggan-steps-in-to-run-early-stage-research-at-rare-disease-specialist-biomarin/\" target=\"_blank\">Harvard 'MacArthur genius' Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://endpts.com/harvard-macarthur-genius-kevin-eggan-steps-in-to-run-early-stage-research-at-rare-disease-specialist-biomarin/\" target=\"_blank\">Harvard 'MacArthur genius' Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>"
    },
    "source": {
      "href": "https://endpts.com",
      "title": "Endpoints News"
    },
    "sub_articles": []
  },
  {
    "title": "BUZZ-U.S. STOCKS ON THE MOVE-Cinemark Holdings, Eidos Therapeutics, DraftKings, AMC Entertainment - Nasdaq",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "BUZZ-U.S. STOCKS ON THE MOVE-Cinemark Holdings, Eidos Therapeutics, DraftKings, AMC Entertainment - Nasdaq"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cinemark-holdings-eidos-therapeutics-draftkings-amc"
      }
    ],
    "link": "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cinemark-holdings-eidos-therapeutics-draftkings-amc",
    "id": "CBMicGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYnV6ei11LnMuLXN0b2Nrcy1vbi10aGUtbW92ZS1jaW5lbWFyay1ob2xkaW5ncy1laWRvcy10aGVyYXBldXRpY3MtZHJhZnRraW5ncy1hbWPSAXRodHRwczovL3d3dy5uYXNkYXEuY29tL2FydGljbGVzL2J1enotdS5zLi1zdG9ja3Mtb24tdGhlLW1vdmUtY2luZW1hcmstaG9sZGluZ3MtZWlkb3MtdGhlcmFwZXV0aWNzLWRyYWZ0a2luZ3MtYW1jP2FtcA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:20:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      20,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cinemark-holdings-eidos-therapeutics-draftkings-amc\" target=\"_blank\">BUZZ-U.S. STOCKS ON THE MOVE-Cinemark Holdings, Eidos Therapeutics, DraftKings, AMC Entertainment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-cinemark-holdings-eidos-therapeutics-draftkings-amc\" target=\"_blank\">BUZZ-U.S. STOCKS ON THE MOVE-Cinemark Holdings, Eidos Therapeutics, DraftKings, AMC Entertainment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>"
    },
    "source": {
      "href": "https://www.nasdaq.com",
      "title": "Nasdaq"
    },
    "sub_articles": []
  },
  {
    "title": "Dow Climbs 200 Points While DraftKings Slumps And Bristol Myers, BridgeBio Pharma Announce Acquisitions - Forbes",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Dow Climbs 200 Points While DraftKings Slumps And Bristol Myers, BridgeBio Pharma Announce Acquisitions - Forbes"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.forbes.com/sites/jonathanponciano/2020/10/05/dow-climbs-200-points-draftkings-slumps-and-bristol-myers-bridgebio-pharma-announce-acquisitions/"
      }
    ],
    "link": "https://www.forbes.com/sites/jonathanponciano/2020/10/05/dow-climbs-200-points-draftkings-slumps-and-bristol-myers-bridgebio-pharma-announce-acquisitions/",
    "id": "CAIiEL69UgTi34sPtGwNOiru54EqFQgEKg0IACoGCAowrqkBMKBFMLKAAg",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:55:03 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      55,
      3,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.forbes.com/sites/jonathanponciano/2020/10/05/dow-climbs-200-points-draftkings-slumps-and-bristol-myers-bridgebio-pharma-announce-acquisitions/\" target=\"_blank\">Dow Climbs 200 Points While DraftKings Slumps And Bristol Myers, BridgeBio Pharma Announce Acquisitions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Forbes</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.forbes.com/sites/jonathanponciano/2020/10/05/dow-climbs-200-points-draftkings-slumps-and-bristol-myers-bridgebio-pharma-announce-acquisitions/\" target=\"_blank\">Dow Climbs 200 Points While DraftKings Slumps And Bristol Myers, BridgeBio Pharma Announce Acquisitions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Forbes</font>"
    },
    "source": {
      "href": "https://www.forbes.com",
      "title": "Forbes"
    },
    "sub_articles": []
  },
  {
    "title": "U.S. Stocks Open Higher after Trump Hospitalization, Dow +0.9% - Naharnet",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "U.S. Stocks Open Higher after Trump Hospitalization, Dow +0.9% - Naharnet"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "http://www.naharnet.com/stories/en/275511-u-s-stocks-open-higher-after-trump-hospitalization-dow-0-9"
      }
    ],
    "link": "http://www.naharnet.com/stories/en/275511-u-s-stocks-open-higher-after-trump-hospitalization-dow-0-9",
    "id": "CBMiZGh0dHA6Ly93d3cubmFoYXJuZXQuY29tL3N0b3JpZXMvZW4vMjc1NTExLXUtcy1zdG9ja3Mtb3Blbi1oaWdoZXItYWZ0ZXItdHJ1bXAtaG9zcGl0YWxpemF0aW9uLWRvdy0wLTnSAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:27:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      27,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"http://www.naharnet.com/stories/en/275511-u-s-stocks-open-higher-after-trump-hospitalization-dow-0-9\" target=\"_blank\">U.S. Stocks Open Higher after Trump Hospitalization, Dow +0.9%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Naharnet</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"http://www.naharnet.com/stories/en/275511-u-s-stocks-open-higher-after-trump-hospitalization-dow-0-9\" target=\"_blank\">U.S. Stocks Open Higher after Trump Hospitalization, Dow +0.9%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Naharnet</font>"
    },
    "source": {
      "href": "http://www.naharnet.com",
      "title": "Naharnet"
    },
    "sub_articles": []
  },
  {
    "title": "After weathering failure, rejection and layoffs, ImmunoGen touts a new 'breakthrough' drug in its comeback plan - Endpoints News",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "After weathering failure, rejection and layoffs, ImmunoGen touts a new 'breakthrough' drug in its comeback plan - Endpoints News"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://endpts.com/after-weathering-failure-rejection-and-layoffs-immunogen-touts-a-new-breakthrough-drug-in-its-comeback-plan/"
      }
    ],
    "link": "https://endpts.com/after-weathering-failure-rejection-and-layoffs-immunogen-touts-a-new-breakthrough-drug-in-its-comeback-plan/",
    "id": "CBMif2h0dHBzOi8vZW5kcHRzLmNvbS9hZnRlci13ZWF0aGVyaW5nLWZhaWx1cmUtcmVqZWN0aW9uLWFuZC1sYXlvZmZzLWltbXVub2dlbi10b3V0cy1hLW5ldy1icmVha3Rocm91Z2gtZHJ1Zy1pbi1pdHMtY29tZWJhY2stcGxhbi_SAQA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:24:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      24,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://endpts.com/after-weathering-failure-rejection-and-layoffs-immunogen-touts-a-new-breakthrough-drug-in-its-comeback-plan/\" target=\"_blank\">After weathering failure, rejection and layoffs, ImmunoGen touts a new 'breakthrough' drug in its comeback plan</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://endpts.com/after-weathering-failure-rejection-and-layoffs-immunogen-touts-a-new-breakthrough-drug-in-its-comeback-plan/\" target=\"_blank\">After weathering failure, rejection and layoffs, ImmunoGen touts a new 'breakthrough' drug in its comeback plan</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>"
    },
    "source": {
      "href": "https://endpts.com",
      "title": "Endpoints News"
    },
    "sub_articles": []
  },
  {
    "title": "US Stocks Rise on Signs of Muted Political Risk - marketscreener.com",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "US Stocks Rise on Signs of Muted Political Risk - marketscreener.com"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/"
      }
    ],
    "link": "https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/",
    "id": "CBMiZmh0dHBzOi8vd3d3Lm1hcmtldHNjcmVlbmVyLmNvbS9uZXdzL2xhdGVzdC9VLVMtU3RvY2tzLVJpc2Utb24tU2lnbnMtb2YtTXV0ZWQtUG9saXRpY2FsLVJpc2stLTMxNDg0NDI5L9IBAA",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 14:37:22 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      14,
      37,
      22,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/\" target=\"_blank\">US Stocks Rise on Signs of Muted Political Risk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketscreener.com/news/latest/U-S-Stocks-Rise-on-Signs-of-Muted-Political-Risk--31484429/\" target=\"_blank\">US Stocks Rise on Signs of Muted Political Risk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">marketscreener.com</font>"
    },
    "source": {
      "href": "https://www.marketscreener.com",
      "title": "marketscreener.com"
    },
    "sub_articles": []
  },
  {
    "title": "Dow climbs 260 points amid optimism that Trump will soon be discharged from the hospital - Business Insider India",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "Dow climbs 260 points amid optimism that Trump will soon be discharged from the hospital - Business Insider India"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.businessinsider.in/stock-market/news/dow-climbs-260-points-amid-optimism-that-trump-will-soon-be-discharged-from-the-hospital/articleshow/78496487.cms"
      }
    ],
    "link": "https://www.businessinsider.in/stock-market/news/dow-climbs-260-points-amid-optimism-that-trump-will-soon-be-discharged-from-the-hospital/articleshow/78496487.cms",
    "id": "CBMiogFodHRwczovL3d3dy5idXNpbmVzc2luc2lkZXIuaW4vc3RvY2stbWFya2V0L25ld3MvZG93LWNsaW1icy0yNjAtcG9pbnRzLWFtaWQtb3B0aW1pc20tdGhhdC10cnVtcC13aWxsLXNvb24tYmUtZGlzY2hhcmdlZC1mcm9tLXRoZS1ob3NwaXRhbC9hcnRpY2xlc2hvdy83ODQ5NjQ4Ny5jbXPSAaYBaHR0cHM6Ly93d3cuYnVzaW5lc3NpbnNpZGVyLmluL3N0b2NrLW1hcmtldC9uZXdzL2Rvdy1jbGltYnMtMjYwLXBvaW50cy1hbWlkLW9wdGltaXNtLXRoYXQtdHJ1bXAtd2lsbC1zb29uLWJlLWRpc2NoYXJnZWQtZnJvbS10aGUtaG9zcGl0YWwvYW1wX2FydGljbGVzaG93Lzc4NDk2NDg3LmNtcw",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:58:00 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      58,
      0,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.businessinsider.in/stock-market/news/dow-climbs-260-points-amid-optimism-that-trump-will-soon-be-discharged-from-the-hospital/articleshow/78496487.cms\" target=\"_blank\">Dow climbs 260 points amid optimism that Trump will soon be discharged from the hospital</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Insider India</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.businessinsider.in/stock-market/news/dow-climbs-260-points-amid-optimism-that-trump-will-soon-be-discharged-from-the-hospital/articleshow/78496487.cms\" target=\"_blank\">Dow climbs 260 points amid optimism that Trump will soon be discharged from the hospital</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Insider India</font>"
    },
    "source": {
      "href": "https://www.businessinsider.in",
      "title": "Business Insider India"
    },
    "sub_articles": []
  },
  {
    "title": "US Stocks Open Higher on Muted Signs of Ebbing Political Risk - Marketscreener.com",
    "title_detail": {
      "type": "text/plain",
      "language": null,
      "base": "",
      "value": "US Stocks Open Higher on Muted Signs of Ebbing Political Risk - Marketscreener.com"
    },
    "links": [
      {
        "rel": "alternate",
        "type": "text/html",
        "href": "https://www.marketscreener.com/news/latest/U-S-Stocks-Open-Higher-on-Muted-Signs-of-Ebbing-Political-Risk--31484077/"
      }
    ],
    "link": "https://www.marketscreener.com/news/latest/U-S-Stocks-Open-Higher-on-Muted-Signs-of-Ebbing-Political-Risk--31484077/",
    "id": "CAIiEIqGmi39e7h_eqIO1rG7T_4qGQgEKhAIACoHCAowxZ6VCzC-_6oDMMvTxQY",
    "guidislink": false,
    "published": "Mon, 05 Oct 2020 13:49:38 GMT",
    "published_parsed": [
      2020,
      10,
      5,
      13,
      49,
      38,
      0,
      279,
      0
    ],
    "summary": "<a href=\"https://www.marketscreener.com/news/latest/U-S-Stocks-Open-Higher-on-Muted-Signs-of-Ebbing-Political-Risk--31484077/\" target=\"_blank\">US Stocks Open Higher on Muted Signs of Ebbing Political Risk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketscreener.com</font>",
    "summary_detail": {
      "type": "text/html",
      "language": null,
      "base": "",
      "value": "<a href=\"https://www.marketscreener.com/news/latest/U-S-Stocks-Open-Higher-on-Muted-Signs-of-Ebbing-Political-Risk--31484077/\" target=\"_blank\">US Stocks Open Higher on Muted Signs of Ebbing Political Risk</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Marketscreener.com</font>"
    },
    "source": {
      "href": "https://www.marketscreener.com",
      "title": "Marketscreener.com"
    },
    "sub_articles": []
  }
]